AMEX · Medical - Instruments & Supplies

RVP (RVP) Stock

$0.68 -0.74% AMEX: RVP Healthcare

Valuation

MetricValue
Price$0.68
Market Cap$20.21M
P/E Ratio-1.53
P/B Ratio0.27
P/S Ratio0.55
EPS (TTM)$-0.43
52-Week High$1.14
52-Week Low$0.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.57%
ROA-9.09%
ROCE-26.67%
Gross Margin-52.63%
Operating Margin-52.63%
Net Margin-16.93%
Debt/Equity0.01
Current Ratio6.30

Annual Financials (USD)

Metric20212022202320242025
Revenue$188.0M$95.0M$44.0M$33.0M$38.0M
Operating Profit$73.0M$-1.0M$-11.0M$-21.0M$-20.0M
Net Profit$56.0M$5.0M$-7.0M$-12.0M$-13.0M
EPS$1.63$0.15$-0.24$-0.40$-0.43
Op Margin38.5%-0.9%-26.4%-63.9%-52.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$213.0M$211.0M$180.0M$161.0M$143.0M
Total Liabilities$114.0M$104.0M$80.0M$74.0M$68.0M
Cash$29.0M$20.0M$13.0M$4.0M$3.0M
Borrowings$4.0M$3.0M$2.0M$1.0M$1.0M

Latest News

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders Business Wire · Jun 30, 2026 Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y Zacks · May 21, 2026 Retractable Technologies: Q1 Earnings Snapshot Associated Press · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$33.0M$17.0M$3.0M$-12.0M$-7.0M
Investing Cash Flow$-121.0M$-48.0M$-12.0M$2.0M$5.0M
Financing Cash Flow$46.0M$6.0M$1.0M$0$0
Net Cash Flow$12.0M$-9.0M$-7.0M$-8.0M$-2.0M
Free Cash Flow$-26.0M$0$2.0M$-13.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-36.41%
Quick Ratio4.17
Interest Coverage—
Return 1Y7.46%
Return 3Y-38.46%
Return 5Y-93.14%

Ownership

Insiders Held59.23%
Institutions Held8.32%
Institutions Float Held20.42%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC581,7362026-03-31
Eversept Partners, LP580,9192026-03-31
Renaissance Technologies, LLC404,0072026-03-31
Blackrock Inc.241,1222026-03-31
Geode Capital Management, LLC149,4482026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLGN $0.27 -9.04% -0.48 $3.54M 0.00%
FEMY $3.06 -17.52% -0.74 $9.24M 0.00%
HBIO $6.10 +0.16% -0.42 $27.51M 0.00%
NRSNNeuroSense Therapeutics Ltd. $0.60 -0.35% -1.35 $21.21M 0.00%
NRXS $6.53 -3.12% -116.50 $80.87M 0.00%

About RVP

RVP is led by CEO Thomas J. Shaw, employs 221 people, headquartered in US, publicly traded since 2001.

RVP stock trades at $0.68 with a market capitalization of $20.21M. The stock is valued at a price-to-earnings (P/E) ratio of -1.53, price-to-book of 0.27, price-to-sales of 0.55. Over the past 52 weeks the stock has ranged between $0.60 and $1.14, and currently trades 40.4% below its 52-week high.

On profitability, RVP generates a return on equity (ROE) of -17.57%, return on capital employed of -26.67%, an operating margin of -52.63%, a net profit margin of -16.93%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides